Kazuhide Nakayama

A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai et al. · Nature Communications · 2021 · 211 citations · Full text

Life Sciences, Biotechnology, Immunology +17

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma

Kazuhide Nakayama, Magdalena M. Szewczyk, Carlo dela Seña et al. · Oncotarget · 2018 · 144 citations · Full text

Medicine, Oncology, Pharmacology +10

A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells

Yoshinori Ishikawa, Kanae Gamo, Masato Yabuki et al. · Molecular Cancer Therapeutics · 2016 · 105 citations

Medicine, Molecular Biology, Oncology +13

The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation

Daisuke Nakata, Shoichi Nakao, Kazuhide Nakayama et al. · Biochemical and Biophysical Research Communications · 2016 · 67 citations

Life Sciences, Genetics, Molecular Biology +12

Role of Neph2 in pontine nuclei formation in the developing hindbrain

Kazuhiko Nishida, Kazuhide Nakayama, Saori Yoshimura et al. · Molecular and Cellular Neuroscience · 2011 · 33 citations

Life Sciences, Neurobiology, Neuroscience +14